Average Co-Inventor Count = 7.62
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Forma Therapeutics, Inc. (24 from 125 patents)
2. Valo Early Discovery, Inc. (5 from 15 patents)
3. Valo Health, Inc. (3 from 29 patents)
32 patents:
1. 12018030 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
2. 11795171 - Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
3. 11739071 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
4. 11111229 - Tetrahydroquinoline compositions as BET bromodomain inhibitors
5. 11084831 - Benzopiperazine compositions as BET bromodomain inhibitors
6. 10981915 - Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
7. 10934299 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
8. 10927130 - Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
9. 10906916 - Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
10. 10836741 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
11. 10703764 - Benzopiperazine compositions as BET bromodomain inhibitors
12. 10611750 - Tetrahydroquinoline compositions as bet bromodomain inhibitors
13. 10519127 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
14. 10519128 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
15. 10519129 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors